Object controller digital twin system
US-2025272454-A1 · Aug 28, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wang Hexiang patents
Wang Hexiang is listed as an inventor on 39 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Hexiang |
| Total patents | 39 |
| First publication | Jun 25, 2015 |
| Latest publication | Aug 28, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
US-2025205345-A1 · Jun 26, 2025 · US
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
US-2024366769-A1 · Nov 7, 2024 · US
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
US-2024366770-A1 · Nov 7, 2024 · US
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and method of use
US-2024246977-A1 · Jul 25, 2024 · US
Self-propelled soft robot body
US-11950763-B2 · Apr 9, 2024 · US
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
US-2023322761-A1 · Oct 12, 2023 · US
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inidbitors with e3 ligase ligand and methods of use
US-2023167118-A1 · Jun 1, 2023 · US
Benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases
US-11472788-B2 · Oct 18, 2022 · US
Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use
US-2022281876-A1 · Sep 8, 2022 · US
Recent patents
Latest publications not already listed above.
Amide-substituted imidazo compounds as selective inhibitors of indoleamine 2,3-dioxygenases
US-2022227762-A1 · Jul 21, 2022 · US
Treatment cancers using a combination comprising PARP inhibitors
US-11202782-B2 · Dec 21, 2021 · US
Maintenance therapy of a parp inhibitor in treating gastric cancer
US-2021205323-A1 · Jul 8, 2021 · US
Crystalline forms of salts of fused penta-cyclic dihydrodiazepinocarbazolones, and uses thereof
US-10899763-B2 · Jan 26, 2021 · US
5 or 8-substituted imidazo [1,5-a] pyridines as selective inhibitors of indoleamine and/or tryptophane 2,3-dioxygenases
US-10882856-B2 · Jan 5, 2021 · US
Novel benzoimidazoles as selective inhibitors of indoleamine 2,3-dioxygenases
US-2020317638-A1 · Oct 8, 2020 · US
Self-Propelled Soft Robot Body
US-2020221938-A1 · Jul 16, 2020 · US
Crystalline forms of salts of fused tera or penta-cyclic dihydrodiazepinocarazolones, and uses thereof
US-2020157103-A1 · May 21, 2020 · US
Treatment of cancers using a combination comprising parp inhibitors, temozolomide and/or radiation therapy
US-2020155567-A1 · May 21, 2020 · US
5 or 8-substituted imidazo[1,5-a]pyridines as indoleamine and/or tryptophane 2,3-dioxygenases
US-10647714-B2 · May 12, 2020 · US
Treatment cancers using a combination comprising parp inhibitors
US-2020030339-A1 · Jan 30, 2020 · US
NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1,5-a] PYRIDINES AS SELECTIVE INHIBITORS OF INDOLEAMINE AND/OR TRYPTOPHANE 2,3-DIOXYGENASES
US-2020024273-A1 · Jan 23, 2020 · US
Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
US-10501467-B2 · Dec 10, 2019 · US
Process for preparing a PARP inhibitor, crystalline forms, and uses thereof
US-10457680-B2 · Oct 29, 2019 · US
NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1,5-a]PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2,3-DIOXYGENASES
US-2019284184-A1 · Sep 19, 2019 · US
Process for preparing a parp inhibitor, crystalline forms, and uses thereof
US-2019177325-A1 · Jun 13, 2019 · US
5 or 8-substituted imidazo[1, 5-a] pyridines as indoleamine and/or tryptophane 2, 3-dioxygenases
US-10280163-B2 · May 7, 2019 · US
Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as parp inhibitors
US-2019016731-A1 · Jan 17, 2019 · US
Fused tetra or penta-cyclic dihydrodiazepinocarbazolones as PARP inhibitors
US-10112952-B2 · Oct 30, 2018 · US
NOVEL 5 OR 8-SUBSTITUTED IMIDAZO[1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
US-2018072716-A1 · Mar 15, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Beigene Ltd | 29 |
| Beigene Switzerland Gmbh | 4 |
| Univ Tsinghua | 2 |
| Zhou Changyou | 2 |
| Ren Bo | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 34 |
| A61K31/551 | 15 |
| C07D487/04 | 14 |
| C07D471/04 | 13 |
| C07D471/22 | 11 |